Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Water Deprivation Protocol

ClinicalTrials.gov ID: NCT01224704

Public ClinicalTrials.gov record NCT01224704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 2:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessment of Thirst and Role of Water/Electrolytes Homeostasis During Water Deprivation in Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Background: \- One area in which obese and lean individuals may be different is how their bodies handle water balance and thirst. Studies done in animals suggest that individuals with greater body fat may tolerate periods without water better than lean animals. Other research has found a link between the ability to tolerate periods without water and increased body weight. Researchers are interested in studying whether the ability to tolerate periods without water and ability to feel thirst might differ in lean versus obese individuals. Objectives: \- To evaluate the effects of water deprivation and feelings of thirst in lean and obese individuals. Eligibility: \- Healthy individuals at least 18 years of age who are either lean (body mass index less than 26 kg/m(2)) or obese (body mass index at least 35 kg/m(2)). Design: * Participants will be screened with a medical history, physical examination, and blood and urine tests. * Participants will spend the entire study (13 days) as inpatients at the National Institutes of Health Clinical Center. * Participants will have the following tests and procedures: * Body composition assessment (using low-level x-rays) to determine the percentage of fat tissue in the body. * Oral glucose tolerance test (similar to that often used to diagnose diabetes). Individuals who are suspected to have diabetes will not be allowed to continue with the study. * High salt infusion test, in which an infusion of saline (salt water) will be given for 2 hours and participants will respond to questions about how hungry and thirsty they feel during the procedure. * Water deprivation test, in which participants will go for 24 hours without water or food and respond to questions about how hungry and thirsty they feel. * 24-hour stay in a metabolic chamber to determine how many calories participants burn in a day. * A series of questionnaires about participants' eating habits, feelings about food, and personal feelings, as well as computer-based tests involving the performance of various tasks. * Measurement of free-living energy using doubly-labeled water, in which participants will drink a sample of water with extra-heavy atoms of hydrogen and oxygen to evaluate the amount of water in the body. * 24-hour urine collection. * Frequent blood samples, urine collection, and fat tissue biopsies during the various study procedures. * After the end of the 13-day study, participants will return after 1 week for a final urine collection....

Study identification

NCT ID
NCT01224704
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
75 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2010
Primary completion
Sep 8, 2018
Completion
Mar 27, 2019
Last update posted
Aug 27, 2026

2010 – 2019

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
NIDDK, Phoenix Phoenix Arizona 85014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01224704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01224704 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →